A new study published in NEJM found that bempedoic acid (Nexletol—Esperion Therapeutics) modestly reduced the risk of heart attacks, strokes, and other complications from heart disease. However, it did not reduce the overall mortality rate. Bempedoic acid was approved by FDA 3 years ago to reduce low-density lipoprotein (LDL) levels.

A new study in Pediatrics found that in recent years opioids were the leading cause of fatal poisonings among children aged 5 years and younger in the United States.

FDA announced it is taking steps to curb illicit importation of the animal sedative xylazine, which is frequently being mixed with illegal street drugs.

A new report from the Global Healthy Living Foundation and the consultant company IQVIA found that pharmacists in the United States administered more recommended routine vaccinations compared with physicians from 2020 to 2021.

FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.